FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18663511000001100: Palexia SR 50mg tablets (Grunenthal Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-May 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63936601000001113 Palexia SR 50mg tablets (Grunenthal Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63936701000001115 Palexia SR 50mg tablets (Grunenthal Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palexia SR 50mg tablets (Grunenthal Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Is a Tapentadol 50mg modified-release tablets true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has active ingredient Tapentadol true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has specific active ingredient Tapentadol hydrochloride true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Is a Palexia SR true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) Has basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Palexia SR 50mg tablets (Grunenthal Ltd) 28 tablet 4 x 7 tablets Has AMP True Palexia SR 50mg tablets (Grunenthal Ltd) Inferred relationship Existential restriction modifier
Palexia SR 50mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has AMP True Palexia SR 50mg tablets (Grunenthal Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start